MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients

被引：0
|
作者：
Florence Pache
Hanna Zimmermann
Janine Mikolajczak
Sophie Schumacher
Anna Lacheta
Frederike C. Oertel
Judith Bellmann-Strobl
Sven Jarius
Brigitte Wildemann
Markus Reindl
Amy Waldman
Kerstin Soelberg
Nasrin Asgari
Marius Ringelstein
Orhan Aktas
Nikolai Gross
Mathias Buttmann
Thomas Ach
Klemens Ruprecht
Friedemann Paul
Alexander U. Brandt
机构：
[1] Charité – Universitätsmedizin Berlin,NeuroCure Clinical Research Center (NCRC)
[2] Charité – Universitätsmedizin Berlin,Department of Neurology
[3] University of Heidelberg,Molecular Neuroimmunology Group, Department of Neurology
[4] Medical University of Innsbruck,Clinical Department of Neurology
[5] Children’s Hospital of Philadelphia,Division of Neurology
[6] Vejle Hospital,Department of Neurology
[7] University of Southern Denmark,Department of Neurobiology, Institute of Molecular Medicine
[8] Heinrich Heine University,Department of Neurology, Medical Faculty
[9] University of Freiburg,Department of Ophthalmology, Medical Faculty
[10] University of Würzburg,Department of Neurology
[11] University of Würzburg,Department of Ophthalmology
[12] Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin,Experimental and Clinical Research Center
来源：
Journal of Neuroinflammation | / 13卷
关键词：
Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG); aquaporin-4 antibodies (AQP4-IgG); NMO-IgG; neuromyelitis optica; Devic syndrome; neuromyelitis optica spectrum disorders (NMOSD); optic neuritis; optical coherence tomography; visual evoked potentials; visual acuity; retinal neuro-axonal damage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 37 条
  • [31] Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning
    Sotirchos, Elias S.
    Filippatou, Angeliki
    Fitzgerald, Kathryn C.
    Salama, Sara
    Pardo, Santiago
    Wang, Jiangxia
    Ogbuokiri, Esther
    Cowley, Norah J.
    Pellegrini, Nicole
    Murphy, Olwen C.
    Mealy, Maureen A.
    Prince, Jerry L.
    Levy, Michael
    Calabresi, Peter A.
    Saidha, Shiv
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (11) : 1360 - 1371
  • [32] MOG-IgG in NMO and related disorders: a multicenter study. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment, and long-term outcome
    Jarius, S.
    Ruprecht, K.
    Kleiter, I.
    Borisow, N.
    Asgari, N.
    Pitarokoili, K.
    Pache, F.
    Stich, O.
    Beume, L-A
    Huemmert, M. W.
    Ringelstein, M.
    Trebst, C.
    Winkelmann, A.
    Schwarz, A.
    Buttmann, M.
    Zimmermann, H.
    Kuchling, J.
    Franciotta, D.
    Capobianco, M.
    Siebert, E.
    Lukas, C.
    Korporal-Kuhnke, M.
    Haas, J.
    Fechner, K.
    Brandt, A. U.
    Schanda, K.
    Aktas, O.
    Paul, F.
    Reindl, M.
    Wildemann, B.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 409 - 409
  • [33] Blood brain barrier (BBB) impairment in NMO-IgG seropositive patients: An aquaporine-4 (AW-4) related damage?
    Tortorella, Carla
    Ruggieri, Maddalena
    Zimatore, Giovan. Ni Bosco
    Frigeri, Antonio
    Lia, Anna
    Di Monte, Elisabetta
    Ghezzi, Angelo
    Rizzo, A.
    Amato, Maria
    Hakiki, Bahia
    Patti, Francesco
    Lugaresi, Alessandra
    Merelli, Elisa
    Livrea, Paolo
    Svelto, Maria
    Trojano, Maria
    NEUROLOGY, 2008, 70 (11) : A268 - A268
  • [34] Diagnostic utility and seroprevalence of AQP4/MOG-IgG in a consecutive cohort of patients undergoing evaluation for suspected CNS inflammatory demyelinating disorders: Mayo clinic/Sri Lankan collaborative study
    Senanayake, B.
    Wijesekera, J.
    Ranawaka, U.
    Riffsy, M.
    Sagen, J.
    Fryer, J.
    Schmeling, J.
    Majed, M.
    Pittock, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 797 - 797
  • [35] Rapid Administration of High-Dose Intravenous Methylprednisolone Improves Visual Outcomes After Optic Neuritis in Patients With AQP4-IgG-Positive NMOSD
    Akaishi, Tetsuya
    Takeshita, Takayuki
    Himori, Noriko
    Takahashi, Toshiyuki
    Misu, Tatsuro
    Ogawa, Ryo
    Kaneko, Kimihiko
    Fujimori, Juichi
    Abe, Michiaki
    Ishii, Tadashi
    Fujihara, Kazuo
    Aoki, Masashi
    Nakazawa, Toru
    Nakashima, Ichiro
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [36] SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab
    Bennett, Jeffrey L.
    Fujihara, Kazuo
    Kim, Ho Jin
    Marignier, Romain
    O'Connor, Kevin C.
    Sergott, Robert C.
    Traboulsee, Anthony
    Wiendl, Heinz
    Wuerfel, Jens
    Zamvil, Scott S.
    Anania, Veronica G.
    Buffels, Regine
    Kunzel, Thomas
    Lekkerkerker, Annemarie N.
    Lennon-Chrimes, Sian
    Pittock, Sean J.
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [37] Comparative Analysis of Visual Characteristics and Neuro-axonal Damage across AQP4-IgG+ Neuromyelitis Optica, MOGAD, and Double Seronegative NMOSD patients presenting with Optic Neuritis
    Jain, Surbhi
    Mahadevan, Anita
    Bhat, Maya
    Kumar, Vinay
    Netravathi, M.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 951 - 952
1234